115 related articles for article (PubMed ID: 7700989)
1. Isolation and characterization of platelet-activating factor receptor binding antagonists from Biota orientalis.
Yang HO; Suh DY; Han BH
Planta Med; 1995 Feb; 61(1):37-40. PubMed ID: 7700989
[TBL] [Abstract][Full Text] [Related]
2. Pinusolidic acid: a platelet-activating factor inhibitor from Biota orientalis.
Yang HO; Han BH
Planta Med; 1998 Feb; 64(1):72-4. PubMed ID: 9491770
[TBL] [Abstract][Full Text] [Related]
3. In vitro platelet-activating factor receptor binding inhibitory activity of pinusolide derivatives: a structure-activity study.
Han BH; Yang HO; Kang YH; Suh DY; Go HJ; Song WJ; Kim YC; Park MK
J Med Chem; 1998 Jul; 41(14):2626-30. PubMed ID: 9651167
[TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effect of kaempferol against binding of platelet activating factor to its receptor].
Zang BX; Jin M; Wu W; Chen WM; Piao YZ; Li JR
Zhongguo Zhong Yao Za Zhi; 2004 Aug; 29(8):789-91. PubMed ID: 15506296
[TBL] [Abstract][Full Text] [Related]
5. Pinusolidic acid: a platelet-activating factor inhibitor from Biota orientalis.
Yang HO; Han BH
Planta Med; 1998 Feb; 64(1):73-4. PubMed ID: 17253221
[TBL] [Abstract][Full Text] [Related]
6. The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor.
Shen TY; Hwang SB; Chang MN; Doebber TW; Lam MH; Wu MS; Wang X
Int J Tissue React; 1985; 7(5):339-43. PubMed ID: 2997065
[TBL] [Abstract][Full Text] [Related]
7. Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors.
Hwang SB; Lam MH; Hsu AH
Mol Pharmacol; 1989 Jan; 35(1):48-58. PubMed ID: 2536468
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor (PAF) receptor binding antagonists from Alpinia officinarum.
Fan GJ; Kang YH; Han YN; Han BH
Bioorg Med Chem Lett; 2007 Dec; 17(24):6720-2. PubMed ID: 17964782
[TBL] [Abstract][Full Text] [Related]
10. Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets.
Morrison WJ; Shukla SD
J Pharmacol Exp Ther; 1989 Sep; 250(3):831-5. PubMed ID: 2550620
[TBL] [Abstract][Full Text] [Related]
11. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
Tahraoui L; Floch A; Cavero I
J Pharmacol Exp Ther; 1990 Mar; 252(3):1221-7. PubMed ID: 2156995
[TBL] [Abstract][Full Text] [Related]
12. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies.
Ortega MP; García MC; Gijón MA; de Casa-Juana MF; Priego JG; Sanchez Crespo M; Sunkel C
J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor binding to human platelet membranes.
Valone FH; Ruis NM
Biotechnol Appl Biochem; 1986 Oct; 8(5):465-70. PubMed ID: 3021183
[TBL] [Abstract][Full Text] [Related]
14. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
Tahraoui L; Floch A; Mondot S; Cavero I
Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
[TBL] [Abstract][Full Text] [Related]
15. Alpha-bulnesene, a novel PAF receptor antagonist isolated from Pogostemon cablin.
Hsu HC; Yang WC; Tsai WJ; Chen CC; Huang HY; Tsai YC
Biochem Biophys Res Commun; 2006 Jul; 345(3):1033-8. PubMed ID: 16712790
[TBL] [Abstract][Full Text] [Related]
16. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
Hwang SB; Lam MH; Szalkowski DM; MacIntyre DE; Bach TJ; Luell S; Meuer R; Sahoo SP; Alberts AW; Chabala JC
J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114
[TBL] [Abstract][Full Text] [Related]
17. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S
Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of platelet-activating factor receptor binding by aporphine and phenanthrenoid alkaloids from Aromadendron elegans.
Jantan I; Rafi IA; Jalil J
Planta Med; 2001 Jul; 67(5):466-7. PubMed ID: 11488464
[TBL] [Abstract][Full Text] [Related]
19. Yangambin: a new naturally-occurring platelet-activating factor receptor antagonist: binding and in vitro functional studies.
Castro-Faria-Neto HC; Bozza PT; Cruz HN; Silva CL; Violante FA; Barbosa-Filho JM; Thomas G; Martins MA; Tibiriçá EV; Noel F
Planta Med; 1995 Apr; 61(2):101-5. PubMed ID: 7753913
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor (PAF) receptor binding activity of the roots of Enicosanthellum pulchrum.
Nordin N; Jalil J; Jantan I; Murad S
Pharm Biol; 2012 Mar; 50(3):284-90. PubMed ID: 22103812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
